There was some limited evidence of e-cigarette-induced IL6 and TNF downregulation, and NFκB1 upregulation [22, 49], suggesting that vapers may be at a lower risk of developing severe COVID-19 versus smokers, but at increased risk versus nonsmokers. This evidence concerns the gene NFKB1 and COVID-19.